Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Texas · 89th Legislature (2025) · Bill

SB 883: Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.

Passed one chamber Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

SB 883 is a bill introduced in the Texas Senate on January 23, 2025. According to its official title, it concerns: Relating to patient access to prescription drugs for off-label use for COVID-19 treatment. Primary sponsor: Angela Paxton (Republican), Bob Hall (Republican). It lists 2 additional sponsors. Most recent recorded action (April 22, 2025): Referred to Public Health.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Sponsors

Sponsors by party (alphabetical): Republican 4

NameRolePartyChamberDistrict
Angela PaxtonPrimary sponsorRepublicanSenate8
Bob HallPrimary sponsorRepublicanSenate2
Lois KolkhorstCo-sponsorRepublicanSenate18
Kevin SparksCo-sponsorRepublicanSenate31

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Referred to Public Health
  2. Read first time
  3. Received from the Senate
  4. Reported engrossed
  5. Record vote
  6. Passed
  7. Read 3rd time
  8. Record vote
  9. Rules suspended-Regular order of business
  10. Record vote
  11. Read 2nd time & passed to engrossment
  12. Record vote

Showing 12 most recent of 28 actions. Full history

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source